INT MEDICAL (01501) has announced that the company applied to the Listing Committee of The Stock Exchange of Hong Kong Limited for approval to list and trade 71,786,600 H-shares, which are intended to be converted from 71,786,600 domestic shares held by 12 shareholders. The company is pleased to announce that the Stock Exchange granted the listing approval on May 13, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments